Merijn Eikelenboom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merijn Eikelenboom has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Brenda W. J. H. Penninx
Amsterdam UMC
4 shared publications Johannes H. Smit
Department of Psychiatry,the Amsterdam Public Health Institute, VU University Medical Center Amsterdam/GGZ inGeest,Amsterdam,The Netherlands
3 shared publications- Koen Schruers
Maastricht University
3 shared publications - Neeltje M. Batelaan
Department of Psychiatry, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, North Holland, 1081HV, The Netherlands, 31 0204444444
3 shared publications Aartjan T. F. Beekman
Department of Psychiatry,the Amsterdam Public Health Institute, VU University Medical Center Amsterdam/GGZ inGeest,Amsterdam,The Netherlands
2 shared publications- Adriaan W. Hoogendoorn
Department of Psychiatry, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, North Holland, 1081HV, The Netherlands, 31 0204444444
2 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5)
Return of Research Results to Participants in Longitudinal Cohort Studies in Health Research: Findings From 24 Cohorts of the Amsterdam Cohort Hub
Background: Returning research results to participants is increasingly recognised as part of participant‐centred health research. How this is implemented in longitudinal cohort studies is not yet well characterised. This study aims to provide a descriptive overview of current result return practices across diverse cohort studies in the Netherlands. Methods: Drawing on the Amsterdam Cohort Hub, an infrastructure of population‐based and patient‐based cohorts in the Netherlands, representatives of 24 affiliated cohort studies completed a structured questionnaire administered via individual interviews. The questionnaire covered what results are returned, to whom, when and how. Individual‐level and group‐level return were distinguished. Cohorts also reported on motivations for returning results and barriers encountered in doing so. Data were summarised descriptively using frequencies. Results: Individual‐level results beyond incidental findings were returned by 15 cohorts (65.2%), while group‐level results were returned by 23 cohorts (96%). Individual‐level return primarily involved physical and laboratory measures or was embedded in routine clinical care. Group‐level results were mainly shared through newsletters. Practices varied by cohort type and were shaped by ethical considerations and practical constraints. Concerns about participant misinterpretation and limited resources were the most reported barriers. Conclusion: Return of research results is widely practised across cohort studies, but varies considerably in approach, shaped by ethical considerations, perceived communication risks, and financial and practical constraints. This descriptive overview of current practices may serve as a starting point for cohorts seeking to reflect on or develop their own result return procedures. Future research should examine the effects of various forms of result return on participant engagement and retention, as well as the role of participant preferences in shaping these practices. Patient or Public Contribution: This study includes a descriptive inventory of patient and public involvement in longitudinal cohort studies, in the form of result return practices. The findings are directly relevant to research participants, as they concern how cohort studies communicate research results to the people who contribute their data. The results may inform how cohorts develop and improve their participant communication strategies in the future.
- 3 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5)
Open AccessReturn of Research Results to Participants in Longitudinal Cohort Studies in Health Research: Findings From 24 Cohorts of the Amsterdam Cohort Hub
Background: Returning research results to participants is increasingly recognised as part of participant‐centred health research. How this is implemented in longitudinal cohort studies is not yet well characterised. This study aims to provide a descriptive overview of current result return practices across diverse cohort studies in the Netherlands. Methods: Drawing on the Amsterdam Cohort Hub, an infrastructure of population‐based and patient‐based cohorts in the Netherlands, representatives of 24 affiliated cohort studies completed a structured questionnaire administered via individual interviews. The questionnaire covered what results are returned, to whom, when and how. Individual‐level and group‐level return were distinguished. Cohorts also reported on motivations for returning results and barriers encountered in doing so. Data were summarised descriptively using frequencies. Results: Individual‐level results beyond incidental findings were returned by 15 cohorts (65.2%), while group‐level results were returned by 23 cohorts (96%). Individual‐level return primarily involved physical and laboratory measures or was embedded in routine clinical care. Group‐level results were mainly shared through newsletters. Practices varied by cohort type and were shaped by ethical considerations and practical constraints. Concerns about participant misinterpretation and limited resources were the most reported barriers. Conclusion: Return of research results is widely practised across cohort studies, but varies considerably in approach, shaped by ethical considerations, perceived communication risks, and financial and practical constraints. This descriptive overview of current practices may serve as a starting point for cohorts seeking to reflect on or develop their own result return procedures. Future research should examine the effects of various forms of result return on participant engagement and retention, as well as the role of participant preferences in shaping these practices. Patient or Public Contribution: This study includes a descriptive inventory of patient and public involvement in longitudinal cohort studies, in the form of result return practices. The findings are directly relevant to research participants, as they concern how cohort studies communicate research results to the people who contribute their data. The results may inform how cohorts develop and improve their participant communication strategies in the future.
- Open Access
- 9 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e94288
Transcranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial
Background: Obsessive-compulsive disorder (OCD) is a disabling mental disorder, characterized by obsessions, compulsions, and substantial morbidity. Approximately 50% of adults with OCD fail to achieve satisfactory outcomes from first-line treatments, such as exposure therapy with response prevention (ERP), with or without medication. This leads to chronic social, educational, and occupational impairment. While invasive procedures such as deep brain stimulation are available for severe, treatment-refractory cases, a need remains for less invasive alternatives. Repetitive transcranial magnetic stimulation (rTMS), a noninvasive intervention, shows promise in reducing OCD symptoms. Unlike in depression, rTMS is not yet reimbursed for OCD in the Dutch healthcare system. Objective: This study examines the efficacy and cost-effectiveness of low-frequency (1Hz) rTMS targeting the presupplementary motor area (pre-SMA) compared to sham rTMS as an adjuvant treatment to ERP in adults with OCD with inadequate response to first-line treatment. Methods: A total of 250 adults with OCD will be enrolled in this multicenter randomized controlled trial. Participants will be randomly assigned to ERP combined with either active or sham 1Hz rTMS over the pre-SMA. Treatment is administered 4 times weekly for at least 5 weeks (20 rTMS-ERP sessions), with optional extension of 1 to 2 weeks, up to 28 rTMS-ERP sessions. Clinical assessments occur at baseline, weekly during treatment, posttreatment, and at 3, 6, and 12 months follow-up. Participants undergo pre- and posttreatment (functional) (MRI) scans, including a symptom provocation task. Blood sampling takes place pre- and posttreatment and at 3-month follow-up. The primary outcome is OCD severity at posttreatment, as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes include functional improvement, quality of life, and societal costs. Pretreatment symptom profiles, genotype, and brain network topology will be analyzed as predictors of response and relapse risk. Pre-to-post treatment change in blood-based and magnetic resonance (MR)-based neuroplasticity markers will help explore differential mechanisms between ERP alone and combined rTMS-ERP. We expect that the verum rTMS protocol will be cost-effective compared to sham-rTMS. Results: Recruitment started in April 2022, and as of February 2026, 201 participants have been enrolled. Posttreatment assessments are projected to be completed in December 2026, with final one-year follow-up evaluations anticipated by the end of 2027. Conclusions: To our knowledge, this study is the first adequately powered randomized controlled trial examining efficacy, cost-effectiveness, and mechanism of action of rTMS for OCD as adjuvant therapy to ERP. In case of efficacy and/or cost-effectiveness, it will pave the way for rTMS as insured health care for adults with OCD in the Netherlands, and possibly other European countries. Furthermore, this trial will provide insight into the mechanisms of treatment response to intensive ERP, with and without adjunctive rTMS, as well as potential side effects, individual variability, and long-term outcomes in adults with OCD.
- 9 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e94288
Open AccessTranscranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial
Background: Obsessive-compulsive disorder (OCD) is a disabling mental disorder, characterized by obsessions, compulsions, and substantial morbidity. Approximately 50% of adults with OCD fail to achieve satisfactory outcomes from first-line treatments, such as exposure therapy with response prevention (ERP), with or without medication. This leads to chronic social, educational, and occupational impairment. While invasive procedures such as deep brain stimulation are available for severe, treatment-refractory cases, a need remains for less invasive alternatives. Repetitive transcranial magnetic stimulation (rTMS), a noninvasive intervention, shows promise in reducing OCD symptoms. Unlike in depression, rTMS is not yet reimbursed for OCD in the Dutch healthcare system. Objective: This study examines the efficacy and cost-effectiveness of low-frequency (1Hz) rTMS targeting the presupplementary motor area (pre-SMA) compared to sham rTMS as an adjuvant treatment to ERP in adults with OCD with inadequate response to first-line treatment. Methods: A total of 250 adults with OCD will be enrolled in this multicenter randomized controlled trial. Participants will be randomly assigned to ERP combined with either active or sham 1Hz rTMS over the pre-SMA. Treatment is administered 4 times weekly for at least 5 weeks (20 rTMS-ERP sessions), with optional extension of 1 to 2 weeks, up to 28 rTMS-ERP sessions. Clinical assessments occur at baseline, weekly during treatment, posttreatment, and at 3, 6, and 12 months follow-up. Participants undergo pre- and posttreatment (functional) (MRI) scans, including a symptom provocation task. Blood sampling takes place pre- and posttreatment and at 3-month follow-up. The primary outcome is OCD severity at posttreatment, as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes include functional improvement, quality of life, and societal costs. Pretreatment symptom profiles, genotype, and brain network topology will be analyzed as predictors of response and relapse risk. Pre-to-post treatment change in blood-based and magnetic resonance (MR)-based neuroplasticity markers will help explore differential mechanisms between ERP alone and combined rTMS-ERP. We expect that the verum rTMS protocol will be cost-effective compared to sham-rTMS. Results: Recruitment started in April 2022, and as of February 2026, 201 participants have been enrolled. Posttreatment assessments are projected to be completed in December 2026, with final one-year follow-up evaluations anticipated by the end of 2027. Conclusions: To our knowledge, this study is the first adequately powered randomized controlled trial examining efficacy, cost-effectiveness, and mechanism of action of rTMS for OCD as adjuvant therapy to ERP. In case of efficacy and/or cost-effectiveness, it will pave the way for rTMS as insured health care for adults with OCD in the Netherlands, and possibly other European countries. Furthermore, this trial will provide insight into the mechanisms of treatment response to intensive ERP, with and without adjunctive rTMS, as well as potential side effects, individual variability, and long-term outcomes in adults with OCD.
- Open Access
Longterm Temporal Dynamics of Suicidal Ideation: A Dynamic Time Warping Analysis of Depression, Anxiety, Worry, and Mastery
Background: Suicidal ideation (SI) fluctuates over time, yet traditional static risk factors poorly align with its dynamics over time. Understanding dynamic symptom patterns may advance knowledge of the temporal interplay between SI and co-occurring symptoms in adults with depressive and anxiety disorders. Materials and methods: We analyzed six waves (at baseline, and after 2, 4, 6, 9, and 13 years of follow-up) of the Netherlands Study of Depression and Anxiety (NESDA; n = 305, mean age 40.8 years, 62% female) in participants with any SI fluctuation over time. Variables included depressive, anxiety, mastery, and worry symptoms. Dynamic Time Warping (DTW) quantified within-person temporal alignment between SI and other symptoms, and an undirected network and forestplot visualized co-fluctuations. Analyses were stratified by age-groups and sex. Results: Over the years, SI co-fluctuated most strongly with affective and anhedonic depressive symptoms, including sad mood, low capacity for pleasure, low general interest, pessimism, quality of mood, and decreased appetite. Select anxiety (terrified/afraid) and worry (overwhelming worries) items also aligned with SI, whereas mastery items did not. Patterns were broadly consistent across age and gender subgroups. Networks indicated that SI is part of a cluster of depressogenic symptoms but bridges to acute fear and persistent worry. Conclusions: SI is a dynamic phenomenon closely linked to specific depressive, anxiety, and worry symptoms. Interventions targeting mood instability, anhedonia, and uncontrollable worry, combined with real-time monitoring, may improve personalized suicide prevention. DTW provides a framework to identify long-term temporally proximal symptom patterns.
Open AccessLongterm Temporal Dynamics of Suicidal Ideation: A Dynamic Time Warping Analysis of Depression, Anxiety, Worry, and Mastery
Background: Suicidal ideation (SI) fluctuates over time, yet traditional static risk factors poorly align with its dynamics over time. Understanding dynamic symptom patterns may advance knowledge of the temporal interplay between SI and co-occurring symptoms in adults with depressive and anxiety disorders. Materials and methods: We analyzed six waves (at baseline, and after 2, 4, 6, 9, and 13 years of follow-up) of the Netherlands Study of Depression and Anxiety (NESDA; n = 305, mean age 40.8 years, 62% female) in participants with any SI fluctuation over time. Variables included depressive, anxiety, mastery, and worry symptoms. Dynamic Time Warping (DTW) quantified within-person temporal alignment between SI and other symptoms, and an undirected network and forestplot visualized co-fluctuations. Analyses were stratified by age-groups and sex. Results: Over the years, SI co-fluctuated most strongly with affective and anhedonic depressive symptoms, including sad mood, low capacity for pleasure, low general interest, pessimism, quality of mood, and decreased appetite. Select anxiety (terrified/afraid) and worry (overwhelming worries) items also aligned with SI, whereas mastery items did not. Patterns were broadly consistent across age and gender subgroups. Networks indicated that SI is part of a cluster of depressogenic symptoms but bridges to acute fear and persistent worry. Conclusions: SI is a dynamic phenomenon closely linked to specific depressive, anxiety, and worry symptoms. Interventions targeting mood instability, anhedonia, and uncontrollable worry, combined with real-time monitoring, may improve personalized suicide prevention. DTW provides a framework to identify long-term temporally proximal symptom patterns.
- Open Access
- 27 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Transcranial magnetic stimulation for patients with exposure therapy resistant obsessive-compulsive disorder: TETRO - a study protocol for a multicenter randomized controlled trial (Preprint)
BACKGROUND Obsessive-compulsive disorder (OCD) is a disabling mental disorder, characterized by obsessions, compulsions and substantial morbidity. Approximately 50% of adults with OCD fail to achieve satisfactory outcomes from first-line treatments such as exposure therapy with response prevention (ERP) with or without medication. This leads to chronic social, educational, and occupational impairment. While invasive procedures such as deep brain stimulation are available for severe, treatment-refractory cases, a need remains for less invasive alternatives. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive intervention, shows promise in reducing OCD symptoms. Unlike in depression, rTMS is not yet reimbursed for OCD in the Dutch healthcare system. OBJECTIVE This study examines the efficacy and cost-effectiveness of low-frequency (1Hz) rTMS targeting the pre-supplementary motor area (pre-SMA) compared to sham rTMS as an adjuvant treatment to ERP in adults with OCD with inadequate response to first-line treatment. METHODS 250 adults with OCD will be enrolled in this multicenter randomized controlled trial. Participants will be randomly assigned to ERP combined with either active or sham 1Hz rTMS over the pre-SMA. Treatment is administered four times weekly for at least five weeks (20 rTMS-ERP sessions), with optional extension of one to two weeks, up to 28 rTMS-ERP sessions. Clinical assessments occur at baseline, weekly during treatment, post-treatment, and at 3, 6, and 12 months follow-up. Participants undergo pre- and post-treatment (functional) MRI scans, including a symptom provocation task. Blood sampling takes place pre- and post-treatment and at 3 months follow-up. The primary outcome is OCD severity at post-treatment, as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes include functional improvement, quality of life and societal costs. Pre-treatment symptom profiles, genotype, and brain network topology will be analyzed as predictors of response and relapse risk. Pre-to-post treatment change in blood-based and MR-based neuroplasticity markers will help explore differential mechanisms between ERP alone and combined rTMS-ERP. We expect that the verum rTMS protocol will be (cost-)effective compared to sham-rTMS. RESULTS Recruitment started in April 2022, and as of February 2026, 201 participants have been enrolled. Post-treatment assessments are projected to be completed in December 2026 with final one-year follow-up evaluations anticipated by the end of 2027. CONCLUSIONS To our knowledge, this study is the first adequately-powered randomized controlled trial examining efficacy, cost-effectiveness and mechanism of action of rTMS for OCD as adjuvant therapy to ERP. In case of efficacy and/or cost-effectiveness, it will pave the way for rTMS as insured health care for adults with OCD in the Netherlands, and possibly other European countries. Furthermore, this trial will provide insight into the mechanisms of treatment response to intensive ERP, with and without adjunctive rTMS, as well as potential side effects, individual variability, and long-term outcomes in adults with OCD. CLINICALTRIAL This trial is registered at clinicaltrials.gov with code: NCT05331937, last updated on January 15th 2026.
- 27 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTranscranial magnetic stimulation for patients with exposure therapy resistant obsessive-compulsive disorder: TETRO - a study protocol for a multicenter randomized controlled trial (Preprint)
BACKGROUND Obsessive-compulsive disorder (OCD) is a disabling mental disorder, characterized by obsessions, compulsions and substantial morbidity. Approximately 50% of adults with OCD fail to achieve satisfactory outcomes from first-line treatments such as exposure therapy with response prevention (ERP) with or without medication. This leads to chronic social, educational, and occupational impairment. While invasive procedures such as deep brain stimulation are available for severe, treatment-refractory cases, a need remains for less invasive alternatives. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive intervention, shows promise in reducing OCD symptoms. Unlike in depression, rTMS is not yet reimbursed for OCD in the Dutch healthcare system. OBJECTIVE This study examines the efficacy and cost-effectiveness of low-frequency (1Hz) rTMS targeting the pre-supplementary motor area (pre-SMA) compared to sham rTMS as an adjuvant treatment to ERP in adults with OCD with inadequate response to first-line treatment. METHODS 250 adults with OCD will be enrolled in this multicenter randomized controlled trial. Participants will be randomly assigned to ERP combined with either active or sham 1Hz rTMS over the pre-SMA. Treatment is administered four times weekly for at least five weeks (20 rTMS-ERP sessions), with optional extension of one to two weeks, up to 28 rTMS-ERP sessions. Clinical assessments occur at baseline, weekly during treatment, post-treatment, and at 3, 6, and 12 months follow-up. Participants undergo pre- and post-treatment (functional) MRI scans, including a symptom provocation task. Blood sampling takes place pre- and post-treatment and at 3 months follow-up. The primary outcome is OCD severity at post-treatment, as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes include functional improvement, quality of life and societal costs. Pre-treatment symptom profiles, genotype, and brain network topology will be analyzed as predictors of response and relapse risk. Pre-to-post treatment change in blood-based and MR-based neuroplasticity markers will help explore differential mechanisms between ERP alone and combined rTMS-ERP. We expect that the verum rTMS protocol will be (cost-)effective compared to sham-rTMS. RESULTS Recruitment started in April 2022, and as of February 2026, 201 participants have been enrolled. Post-treatment assessments are projected to be completed in December 2026 with final one-year follow-up evaluations anticipated by the end of 2027. CONCLUSIONS To our knowledge, this study is the first adequately-powered randomized controlled trial examining efficacy, cost-effectiveness and mechanism of action of rTMS for OCD as adjuvant therapy to ERP. In case of efficacy and/or cost-effectiveness, it will pave the way for rTMS as insured health care for adults with OCD in the Netherlands, and possibly other European countries. Furthermore, this trial will provide insight into the mechanisms of treatment response to intensive ERP, with and without adjunctive rTMS, as well as potential side effects, individual variability, and long-term outcomes in adults with OCD. CLINICALTRIAL This trial is registered at clinicaltrials.gov with code: NCT05331937, last updated on January 15th 2026.
- 12 May 2024
- Published by Elsevier in Psychiatry Research
- Vol. 337, 115963
Loneliness in OCD and its determinants
- 12 May 2024
- Published by Elsevier in Psychiatry Research
- Vol. 337, 115963
Loneliness in OCD and its determinants
- Open Access
- 27 August 2022
- Published by Springer Nature in Quality & Quantity
- Vol. 57 (4) , 3183-3197
Investigating people’s lifetime history of suicide attempts: a roadmap for studying interviewer-related error
It is critically important to correctly identify persons with a lifetime history (LTH) of suicide attempts (SA) from both a clinical and research perspective. Face-to-face interviews are often the best available method for researchers to collect data about a complex phenomenon like a LTH of SA. However, extensive survey methodology research has shown that probing sensitive topics like a LTH of SA are sensitive for interviewer-related errors or interviewer effects. Studies investigating these interviewer effects are scarce in the field of suicide studies. This study presents a possible roadmap for study of interviewerrelated measurement error and an exploration of role-dependent behaviour of interviewers by assessing the LTH of SA through an epidemiological design. Data from the baseline assessment of the Netherlands Study of Depression and Anxiety (N = 2981) was used to illustrate the proposed roadmap to study interviewer effects. Results show: : (1) that it was possible to identify the existence of interviewer effects in assessing a LTH of SA; (2) that interviewer effects occurred by probing and clarification activities of the interviewer but not with inadequate formulation of the original question and so give a possible explanation for these effects; and (3) that it was possible to study the impact of these effects on the association between a well-known risk factor and LTH of SA. Applying the Measurement Error framework for systematically examining errors in data collection on suicidality seems a promising method.
- 27 August 2022
- Published by Springer Nature in Quality & Quantity
- Vol. 57 (4) , 3183-3197
Open AccessInvestigating people’s lifetime history of suicide attempts: a roadmap for studying interviewer-related error
It is critically important to correctly identify persons with a lifetime history (LTH) of suicide attempts (SA) from both a clinical and research perspective. Face-to-face interviews are often the best available method for researchers to collect data about a complex phenomenon like a LTH of SA. However, extensive survey methodology research has shown that probing sensitive topics like a LTH of SA are sensitive for interviewer-related errors or interviewer effects. Studies investigating these interviewer effects are scarce in the field of suicide studies. This study presents a possible roadmap for study of interviewerrelated measurement error and an exploration of role-dependent behaviour of interviewers by assessing the LTH of SA through an epidemiological design. Data from the baseline assessment of the Netherlands Study of Depression and Anxiety (N = 2981) was used to illustrate the proposed roadmap to study interviewer effects. Results show: : (1) that it was possible to identify the existence of interviewer effects in assessing a LTH of SA; (2) that interviewer effects occurred by probing and clarification activities of the interviewer but not with inadequate formulation of the original question and so give a possible explanation for these effects; and (3) that it was possible to study the impact of these effects on the association between a well-known risk factor and LTH of SA. Applying the Measurement Error framework for systematically examining errors in data collection on suicidality seems a promising method.
- Open Access
- 10 May 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 59, 58-67
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
- 10 May 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 59, 58-67
Open AccessCannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
- Open Access
- 1 January 2022
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 112, 152284
Associations between personality traits and suicidal ideation and suicide attempts in patients with personality disorders
- 1 January 2022
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 112, 152284
Open AccessAssociations between personality traits and suicidal ideation and suicide attempts in patients with personality disorders
- Open Access
- 15 October 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (20) , 10858
The Effect of Rapport on Data Quality in Face-to-Face Interviews: Beneficial or Detrimental?
The benefits of rapport between interviewers and respondents, in terms of recruiting the latter and motiving them to participate in research, have been generally endorsed. However, there has been less clarity with regard to the association between rapport and data quality. In theory, rapport could be beneficial if it motivates people to give complete and honest responses. On the other hand, efforts to maintain rapport by exhibiting pleasing and socially desirable behaviour could well be detrimental to data quality. In a large longitudinal epidemiological sample, generalized estimating equations (GEE) analyses were used to examine the association between rapport and the following three quality indicators: missing responses, responses to sensitive questions, and consistency of responses. The results of these analyses indicate an association between a high level of rapport and fewer missing responses. In contrast, we found more socially desirable responses for the high-rapport group. Finally, the high-rapport group did not differ from the low-rapport group in terms of the consistency of their responses.
- 15 October 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (20) , 10858
Open AccessThe Effect of Rapport on Data Quality in Face-to-Face Interviews: Beneficial or Detrimental?
The benefits of rapport between interviewers and respondents, in terms of recruiting the latter and motiving them to participate in research, have been generally endorsed. However, there has been less clarity with regard to the association between rapport and data quality. In theory, rapport could be beneficial if it motivates people to give complete and honest responses. On the other hand, efforts to maintain rapport by exhibiting pleasing and socially desirable behaviour could well be detrimental to data quality. In a large longitudinal epidemiological sample, generalized estimating equations (GEE) analyses were used to examine the association between rapport and the following three quality indicators: missing responses, responses to sensitive questions, and consistency of responses. The results of these analyses indicate an association between a high level of rapport and fewer missing responses. In contrast, we found more socially desirable responses for the high-rapport group. Finally, the high-rapport group did not differ from the low-rapport group in terms of the consistency of their responses.